IWAA 2016 Annual Scientific Meeting
As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommenda- tions. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off- label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.
All identified conflicts of interest have been resolved.
Gerald Gleich, M.D. Speaker Consulting/Research Grant: GSK
Other: Board Member: APFED Other: Founder: ImmViz
Other: Royalties: Mayo Clinic,Teva
Richard Henry, M.D. Moderator
Other: Principal Investigator Research: AstraZeneca, Biota, Genentech, Merck, Roche, Sanofi
Joshua Jacobs, M.D. Speaker Consulting/Advisory Board: Dyax, Shire, Valeant Research Grant: Biocryst, CSL Behring, Dyax, Shire Speaker: Dyax, Shire
Rohit Katial, M.D. Speaker Consulting/Advisory Board: AstraZeneca, MEDA, Teva Speaker: MEDA, Teva
David Khan, M.D. Speaker Speaker/Honorarium: Genentech
Other: DSMB: Aimmune
Daniel More, M.D. Speaker Other: Contributor: About.com
Carl Thornblade, M.D. Moderator
Research Study-Independent Contractor: AstraZeneca, Circassia, GSK, Merck, Mylan, Sanofi, Teva
Richard Wasserman, M.D., PhD Speaker
Consulting/Advisory Board: ADMA Biologicals, Baxalta, CSL Behring, Grifols, Kedrion, Prometic, Secretory IgA, Therapure
Honorarium: Baxalta, CSL Behring
Research Grant: ADMA Biologicals, Baxalta, Bioplasma Labs, CSL Behring, Kedrion, Therapure Speaker: Baxalta, CSL Behring
Other: Stocks: Secretory IgA
Kenneth Yeager PhD Speaker Consulting/Advisory Board: Ohio Lawyers Assistance Program Honorarium: ACAAI, Oxford University Press review
Speaker: ACAAI
The following have no relevant financial relationships to disclose: Ernest Charlesworth, M.D. Speaker
Ronald England, M.D. Moderator
Jim Thompson PhD Speaker
Gregory Wickern, M.D. Moderator
Doug Huneywell Planner